Results 21 to 30 of about 3,534,144 (421)

Animal models for the study of depressive disorder

CNS Neuroscience & Therapeutics, 2021
Depressive disorder is one of the most widespread forms of psychiatric pathology, worldwide. According to a report by the World Health Organization, the number of people with depression, globally, is increasing dramatically with each year.
Juhyun Song, Young-Kook Kim
semanticscholar   +1 more source

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

JAMA psychiatry, 2020
This randomized clinical trial examines the efficacy of psilocybin as an adjunct to psychotherapy and other treatments for major depressive disorder.
Alan K. Davis, F. Barrett, Darrick G. May, Mary P. Cosimano, Nathan D. Sepeda, Matthew W. Johnson, P. Finan, R. Griffiths   +7 more
semanticscholar   +1 more source

Depressive disorder at the household level: prevalence and correlates of depressive symptoms among household members

Global Health Action, 2023
Background Globally, an estimated five percent of adults have major depressive disorder. However, little is known about the relationship between these individuals’ depressive symptoms and their household members’ mental health and well-being.
Kondwani Mpinga, Temusa Rukundo, Owen Mwale, Myrrah Kamwiyo, Limbani Thengo, Todd Ruderman, Beatrice Matanje, Fabien Munyaneza, Emilia Connolly, Kazione Kulisewa, Michael Udedi, Chiyembekezo Kachimanga, Luckson Dullie, Ryan McBain   +13 more
doaj   +1 more source

Inositol for depressive disorders [PDF]

Cochrane Database of Systematic Reviews, 2002
There are a number of effective interventions for the treatment of depression. It is possible that the efficacy of these treatments will be improved further by the use of adjunctive therapies such as inositol.1. To determine the effectiveness of inositol in the treatment of depression.2.
Taylor, M, Wilder, H, Bhagwagar, Z, Geddes, J   +3 more
openaire   +3 more sources

The Kimberley assessment of depression of older Indigenous Australians: prevalence of depressive disorders, risk factors and validation of the KICA-dep scale [PDF]

, 2014
This study aimed to develop a culturally acceptable and valid scale to assess depressive symptoms in older Indigenous Australians, to determine the prevalence of depressive disorders in the older Kimberley community, and to investigate the ...
David Atkinson, Dina LoGiudice, Kate Smith, Leon Flicker, Linda Skeaf, Osvaldo P. Almeida, Roslyn Malay, Stephen Fenner, Zoe Hyde   +8 more
core   +6 more sources

Depressive Disorders

, 2021
Major Depressive Disorder (MDD) and other disorders on the depressive spectrum are more prevalent among HIV-infected individuals than in the general population. These illnesses have a significant impact on prevention, engagement and adherence to HIV care, prognosis, illness-related disability, and quality of life.
FERRARI S, BLANCH J, LAVASANI S, BEALL SC, GIBSON SJ, MAGARINI FM, ALBONI S   +6 more
openaire   +2 more sources

Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment‐resistant major depressive disorder

Neuropsychopharmacology Reports, 2020
Aim A substantial proportion of major depressive disorder patients are treatment‐resistant to antidepressant therapy, who require augmentation drugs, or other treatments including electroconvulsive therapy or transcranial magnetic stimulation ...
Katsuhiko Yamasaki, Tomonori Hasegawa, Masatoshi Takeda   +2 more
doaj   +1 more source

Prevalence and correlates of major depressive disorder: a systematic review

Revista Brasileira de Psiquiatria, 2020
Objectives: Major depressive disorder (MDD) is one of the most disabling mental illnesses and it has a significant impact on society. This review aims to provide updated scientific evidence about the epidemiology of MDD.
L. Gutiérrez-Rojas, A. Porras-Segovia, Henry Dunne, N. Andrade-González, J. Cervilla   +4 more
semanticscholar   +1 more source

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Journal of the American Medical Association (JAMA), 2003
CONTEXT Uncertainties exist about prevalence and correlates of major depressive disorder (MDD). OBJECTIVE To present nationally representative data on prevalence and correlates of MDD by Diagnostic and Statistical Manual of Mental Disorders, Fourth ...
R. Kessler, P. Berglund, Olga V. Demler, R. Jin, D. Koretz, K. Merikangas, A. Rush, E. Walters, Philip S. Wang   +8 more
semanticscholar   +1 more source

Role of Interleukin-6 in Depressive Disorder

International Journal of Molecular Sciences, 2020
Major depressive disorder (MDD), which is a leading psychiatric illness across the world, severely affects quality of life and causes an increased incidence of suicide.
Emily Yi-Chih Ting, A. Yang, S. Tsai
semanticscholar   +1 more source